RECENT reports in the United States of America estimate that retrolental fibroplasia is now responsible for one-third of the incidence of blindness in preschool children (Reese,1 1949), while in Great Britain the number of cases has risen rapidly since the disease was first reported there, in 1946. The disease was first described in 1942 by Terry2 and apparently had not previously been recorded; now, some 10 years later, it has become a major problem in pediatric and ophthalmic medicine.
This fact is curious, since the previous generations of ophthalmologists were certainly observers par excellence; furthermore, a careful search of the eyes enucleated over many years at the Birmingham and Midland Eye Hospital failed to reveal more than one specimen which might at all correspond to the pathological description of retrolental fibroplasia. The patient was traced, reexamined, and found not to have qualified for the disease in any way.
CROSSE VM, EVANS PJ. PREVENTION OF RETROLENTAL FIBROPLASIA. AMA Arch Ophthalmol. 1952;48(1):83–87. doi:10.1001/archopht.1952.00920010086012
Customize your JAMA Network experience by selecting one or more topics from the list below.